09:37 AM EST, 11/05/2025 (MT Newswires) -- Perrigo ( PRGO ) said Wednesday that it is starting a strategic review of its infant formula business to assess a "full range of alternatives."

The review will focus on a combination of accelerating cash flows and reassessing Perrigo's ( PRGO ) investment in the business of $240 million, the company said.

In 2025, the infant formula division is expected to generate net sales of about $360 million, which is around 90% of Perrigo's ( PRGO ) global Nutrition category and represents less than 10% of Perrigo's ( PRGO ) annual net sales, the company said.

Perrigo ( PRGO ) said there is no definitive timetable for finalizing the review, and there is no assurance it will lead to any changes or a deal.

Price: 16.65, Change: -3.53, Percent Change: -17.49